Award
Purchase Order #75N98026P01424
Purchase Order for MISEQ I100 PLUS System Awarded to Illumina, Inc.
Buyer
National Institutes of Health
Award Amount
$119,215.62
Ceiling
$119,215.62
Awarded
August 26, 2026
Period of Performance
Aug 26, 2026 – Sep 26, 2026
Identifier
75N98026P01424
NAICS
334516
This award represents a purchase order contract for the procurement of the MISEQ I100 PLUS System, a cutting-edge sequencing platform used in genomics research and diagnostics. The contract recipient, Illumina, Inc., is a leading biotechnology company specializing in genomic analysis technologies, providing advanced sequencing solutions to public and private sectors. The contract supports a significant technological acquisition, enhancing the agency's capabilities in genetic sequencing and analysis, which is vital for scientific research and medical applications. The scope covers the supply and delivery of the MISEQ I100 PLUS System to a specified location in Jean, California, within a one-month performance period, ensuring prompt deployment. The contract was awarded through a purchase order process, indicating a streamlined procurement likely based on existing capabilities or needs, without competitive bidding information available. This short-term agreement highlights a focused acquisition to meet immediate operational requirements, contributing to ongoing advancements in biotechnology applications.
Description
MISEQ I100 PLUS SYSTEM